Earnings Call/Transcript
CSL Finance Q2 FY27 Earnings Call
CSL Finance will hold an earnings conference call on November 3, 2026, at 4:00 PM IST to discuss Q2 and H1 FY27 performance.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
5
Bullish
4
Bearish
20
Neutral
5
Bullish
21
Bearish
15
Neutral
0
Bullish
17
Bearish
5
Neutral
5
Bullish
4
Bearish
5
Neutral
5
Bullish
4
Bearish
15
Neutral
0
Bullish
17
Bearish
15
Neutral
0
Bullish
17
Bearish
15
Neutral
0
Bullish
17
Finance
Non Banking Financial Company (NBFC)
488 Cr
Moderate Risk
5.6
15.2
0.2
0.8
324.90
200.70
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 01, 2026
CSL Finance Ltd (CSLFINANCE) is currently trading at 214.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
CSL Finance Limited is a listed non-banking finance company focused on secured lending to small and medium enterprises (SME) and real estate and non-real estate corporates, operating a 100% secured loan book with an AUM of ₹1,505 crore as of June 30, 2026 and core verticals split between SME Retail and Wholesale real estate lending. Recent operational progress shows resilient asset quality and profitability: Q1FY27 reported revenue of ₹70.35 crore and PAT of ₹22.15 crore, with Gross NPA at 0.95% and Provision Coverage Ratio at 123.20%, reflecting conservative provisioning and active recovery efforts while ROA and ROE improved sequentially in Q1FY27. Management is prioritising a mix shift and efficiency: CSL is rationalising the portfolio to grow granular SME Retail while preserving a niche Wholesale franchise in NCR, revamping its Loan Origination System and digital collections, and undertaking clustered branch reorganisations to raise AUM per branch and employee productivity. Funding and capital position are supportive of growth: credit rating affirmed at A- | Stable, the company has drawn ₹60 crore under a recent NCD issue with ₹90 crore undrawn, a diversified lender base across 35 institutions, and reported net worth of ₹636.70 crore providing headroom to scale lending prudently.
Over the past 52 weeks, CSL Finance Ltd has traded between a low of ₹200.70 and a high of ₹324.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
CSL Finance Ltd has a market capitalization of approximately 487.78. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
CSL Finance Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 5.61 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 487.78 Cr, CSL Finance Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
CSL Finance Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of CSL Finance Ltd is 5.61. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
CSL Finance re-appointed Rohit Gupta as Managing Director for a five-year term from August 10, 2027 to August 9, 2032, subject to shareholder approval at the AGM.
The 81% drop in CSL's first-half net profit was primarily caused by government policy changes, significant one-off restructuring costs, impairments, falling US vaccination rates, and reduced demand for its albumin product in China.
Earnings Call/Transcript
CSL Finance will hold an earnings conference call on November 3, 2026, at 4:00 PM IST to discuss Q2 and H1 FY27 performance.
Board Meeting
CSL Finance will hold a Board meeting on November 2, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.
